RxDoctor Payments Data

David Kingsley, MD

Dermatology · Kearney, NENPI 1366452344

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 59.2% of the total. Reporting peaked in 2021 at $305 and has fallen 65.8% since, to $104 in 2025. That places this record below the midpoint for dermatology clinicians in NE, where the typical reported total is $2,089.

$1,300in general payments, 2019–2025

Across 81 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$770
  • Johnson & Johnson$111
  • E.r. Squibb & Sons, L.L.C.$102
  • Lilly USA, LLC$52
  • Mallinckrodt Hospital Products Inc.$49
  • Sun Pharmaceutical Industries Inc.$48
  • plus $168 from 5 others

What the payments were for

  • Food & beverage$1,300100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,300 in reported general payments places this provider in the 40th percentile of 68 dermatology providers in Nebraska.

See all dermatology providers in Nebraska

Medicare billing

Part B allowed, 2024
$280,829
Medicare patients
863
Services billed
4,977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamcinolone Acetonide227$2,520
Clindamycin Phosphate40$1,478
Mometasone Furoate58$1,389
Clobetasol Propionate37$1,222
MethotrexateMethotrexate Sodium34$1,200
Fluorouracil13$1,098
Doxycycline Hyclate55$1,095
Betamethasone Dipropionate31$1,038
Fluconazole67$905
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc20$882
Dapsone15$806
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$616
Minocycline Hcl17$372
CiclopiroxCiclopirox Olamine22$330
Cephalexin21$293

Paid to pharmacies, not to this prescriber.

Other dermatology in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →